-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Bellerophon Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2015 to Q3 2023.
- Bellerophon Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2023 was -165 %, a 24% decline year-over-year.
- Bellerophon Therapeutics, Inc. annual Return On Equity for 2022 was -207 %, a 222% decline from 2021.
- Bellerophon Therapeutics, Inc. annual Return On Equity for 2021 was -64.2 %, a 9.35% increase from 2020.
- Bellerophon Therapeutics, Inc. annual Return On Equity for 2020 was -70.8 %, a 56.4% increase from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)